176 related articles for article (PubMed ID: 18203649)
1. Cytokeratin fragments in the serum: their utility for the management of oral cancer.
Sawant SS; Zingde SM; Vaidya MM
Oral Oncol; 2008 Aug; 44(8):722-32. PubMed ID: 18203649
[TBL] [Abstract][Full Text] [Related]
2. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma.
Nagler RM; Barak M; Peled M; Ben-Aryeh H; Filatov M; Laufer D
Cancer; 1999 Mar; 85(5):1018-25. PubMed ID: 10091783
[TBL] [Abstract][Full Text] [Related]
3. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
Wakatsuki M; Suzuki Y; Nakamoto S; Ohno T; Ishikawa H; Kiyohara H; Kiyozuka M; Shirai K; Nakayama Y; Nakano T
J Gastroenterol Hepatol; 2007 May; 22(5):715-9. PubMed ID: 17444861
[TBL] [Abstract][Full Text] [Related]
5. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A; Tana R; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
[TBL] [Abstract][Full Text] [Related]
6. Biochemical prognostic factors and risk of relapses in patients with cervical cancer.
Gadducci A; Tana R; Fanucchi A; Genazzani AR
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S23-6. PubMed ID: 17727924
[TBL] [Abstract][Full Text] [Related]
7. Significance of cytokeratin markers TPA, TPA (cyk), TPS and CYFRA 21.1 in metastatic disease.
van Dalen A
Anticancer Res; 1996; 16(4B):2345-9. PubMed ID: 8694567
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of cytokeratins as tumor markers.
Barak V; Goike H; Panaretakis KW; Einarsson R
Clin Biochem; 2004 Jul; 37(7):529-40. PubMed ID: 15234234
[TBL] [Abstract][Full Text] [Related]
10. [Oral cancer--molecular aberrations and tumor markers cellular aberrations].
Nagler R
Harefuah; 2003 Apr; 142(4):272-6, 318, 317. PubMed ID: 12754877
[TBL] [Abstract][Full Text] [Related]
11. A clinicopathologic study on basaloid squamous cell carcinoma in the oral and maxillofacial region.
Yu GY; Gao Y; Peng X; Chen Y; Zhao FY; Wu MJ
Int J Oral Maxillofac Surg; 2008 Nov; 37(11):1003-8. PubMed ID: 18632253
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness of tumor markers in squamous cell carcinoma of the larynx.
Eleftheriadou A; Chalastras T; Ferekidou E; Kyriou L; Yiotakis I; Pappas Z; Ferekidis E; Kandiloros D
Anticancer Res; 2006; 26(3B):2493-7. PubMed ID: 16821638
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of tissue polypeptide antigen in oral squamous cell carcinoma.
Sawant SS; Chaukar DA; Joshi SS; Dange PP; Kannan S; Kane S; D'Cruz AK; Vaidya MM
Oral Oncol; 2011 Feb; 47(2):114-20. PubMed ID: 21130025
[TBL] [Abstract][Full Text] [Related]
14. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
[TBL] [Abstract][Full Text] [Related]
15. Oral squamous cell carcinoma: review of prognostic and predictive factors.
Massano J; Regateiro FS; Januário G; Ferreira A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):67-76. PubMed ID: 16831675
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral lymphangiogenesis in oral squamous cell carcinoma and its clinicopathological significance.
Zhao D; Pan J; Li XQ; Wang XY; Tang C; Xuan M
J Oral Pathol Med; 2008 Nov; 37(10):616-25. PubMed ID: 19012622
[TBL] [Abstract][Full Text] [Related]
17. CYFRA 8/18 in head and neck cancer.
Maass JD; Niemann AM; Lippert BM; Gottschlich S; Folz BJ; Werner JA
Anticancer Res; 1999; 19(4A):2699-701. PubMed ID: 10470223
[TBL] [Abstract][Full Text] [Related]
18. Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19.
Gonzalez-Quintela A; García J; Campos J; Perez LF; Alende MR; Otero E; Abdulkader I; Tomé S
Alcohol; 2006 Jan; 38(1):45-9. PubMed ID: 16762691
[TBL] [Abstract][Full Text] [Related]
19. Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients.
Tamaki S; Sanefuzi N; Kawakami M; Aoki K; Imai Y; Yamanaka Y; Yamamoto K; Ishitani A; Hatake K; Kirita T
Hum Immunol; 2008 Feb; 69(2):88-93. PubMed ID: 18361932
[TBL] [Abstract][Full Text] [Related]
20. Genome wide instability scanning in chewing-tobacco associated oral cancer using inter simple sequence repeat PCR.
Rai R; Kulkarni V; Saranath D
Oral Oncol; 2004 Nov; 40(10):1033-9. PubMed ID: 15509495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
